Canada markets closed

Verona Pharma plc (VRNA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
12.50-0.28 (-2.19%)
At close: 04:00PM EDT
12.50 0.00 (0.00%)
After hours: 04:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
458
40,000
0
Cost of Revenue
-
0
346
0
-
Gross Profit
-
0
112
40,000
-
Operating Expenses
Research Development
11,370
17,216
49,283
79,406
44,505
Selling General and Administrative
61,198
50,353
26,579
33,907
29,772
Total Operating Expenses
73,192
66,465
66,228
97,683
66,010
Operating Income or Loss
-73,192
-66,465
-66,116
-57,683
-66,010
Interest Expense
3,350
2,057
521
340
35
Total Other Income/Expenses Net
715
1,866
-4,632
2,422
924
Income Before Tax
-62,365
-53,895
-68,448
-55,587
-65,000
Income Tax Expense
1,055
474
253
-18
146
Income from Continuing Operations
-63,420
-54,369
-68,701
-55,569
-65,146
Net Income
-63,420
-54,369
-68,701
-55,569
-65,146
Net Income available to common shareholders
-63,420
-54,369
-68,701
-55,569
-65,146
Basic EPS
-0.56
-0.72
-1.04
-0.96
-2.00
Diluted EPS
-0.56
-0.72
-1.04
-0.96
-2.00
Basic Average Shares
78,105
79,268
66,134
59,149
32,867
Diluted Average Shares
78,105
79,268
66,134
59,149
32,867